These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16076390)

  • 1. Combined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant vaccinia virus and a bacterial plasmid both expressing TBE virus non-structural NS1 protein.
    Aleshin SE; Timofeev AV; Khoretonenko MV; Zakharova LG; Pashvykina GV; Stephenson JR; Shneider AM; Altstein AD
    BMC Microbiol; 2005 Aug; 5():45. PubMed ID: 16076390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice.
    Khoretonenko MV; Vorovitch MF; Zakharova LG; Pashvykina GV; Ovsyannikova NV; Stephenson JR; Timofeev AV; Altstein AD; Shneider AM
    Immunol Lett; 2003 Dec; 90(2-3):161-3. PubMed ID: 14687719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis].
    Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics and Extent of Non-Structural Protein 1-Antibody Responses in Tick-Borne Encephalitis Vaccination Breakthroughs and Unvaccinated Patients.
    Stiasny K; Leitner A; Holzmann H; Heinz FX
    Viruses; 2021 May; 13(6):. PubMed ID: 34072119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus.
    Timofeev AV; Butenko VM; Stephenson JR
    Virus Genes; 2004 Jan; 28(1):85-97. PubMed ID: 14739654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A recombinant adenovirus expressing the NS1 nonstructural protein of tick-borne encephalitis virus: some characteristics of the immunologic basis of antiviral action].
    Timofeev AV; Ozherelkov SV; Pronin AV; Deeva AV; Elbert LB; Stefenson JR
    Vopr Virusol; 1997; 42(5):219-22. PubMed ID: 9424847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective activity of a bacterial plasmid, bearing the gene for the tick-borne encephalitis virus NS1 nonstructural protein].
    Timofeev AV; Kondrat'eva IuIu; Karganova GG; Stephenson J
    Vopr Virusol; 2001; 46(1):22-4. PubMed ID: 11233282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice.
    Beicht J; Kubinski M; Zdora I; Puff C; Biermann J; Gerlach T; Baumgärtner W; Sutter G; Osterhaus ADME; Prajeeth CK; Rimmelzwaan GF
    Front Immunol; 2023; 14():1177324. PubMed ID: 37483628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tick-borne encephalitis virus NS3 gene expression does not protect mice from homologous viral challenge.
    Morozova OV; Maksimova TG; Bakhvalova VN
    Viral Immunol; 1999; 12(4):277-80. PubMed ID: 10630787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein.
    Timofeev AV; Ozherelkov SV; Pronin AV; Deeva AV; Karganova GG; Elbert LB; Stephenson JR
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():689-95. PubMed ID: 9568962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model.
    Volpina OM; Volkova TD; Koroev DO; Ivanov VT; Ozherelkov SV; Khoretonenko MV; Vorovitch MF; Stephenson JR; Timofeev AV
    Virus Res; 2005 Sep; 112(1-2):95-9. PubMed ID: 16022903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
    Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
    BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectors of in vivo delayed hypersensitivity in experimental flavivirus infections and vaccination against tick-borne encephalitis in mice].
    Lipovka VA; Khozinskiĭ VV; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):83-8. PubMed ID: 6098109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice.
    Hall RA; Brand TN; Lobigs M; Sangster MY; Howard MJ; Mackenzie JS
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1287-94. PubMed ID: 8683218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel recombinant adenovirus vector expressing a flavivirus non-structural protein protects against lethal flavivirus challenge.
    Jacobs SC
    Clin Sci (Lond); 1993 Aug; 85(2):117-22. PubMed ID: 8403779
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-dose vaccine against tick-borne encephalitis.
    Rumyantsev AA; Goncalvez AP; Giel-Moloney M; Catalan J; Liu Y; Gao QS; Almond J; Kleanthous H; Pugachev KV
    Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13103-8. PubMed ID: 23858441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.